Inflammatory Breast Neoplasms
"Inflammatory Breast Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Metastatic breast cancer characterized by EDEMA and ERYTHEMA of the affected breast due to LYMPHATIC METASTASIS and eventual obstruction of LYMPHATIC VESSELS by the cancer cells.
| Descriptor ID |
D058922
|
| MeSH Number(s) |
C04.588.180.576 C17.800.090.500.576
|
| Concept/Terms |
Inflammatory Breast Neoplasms- Inflammatory Breast Neoplasms
- Breast Neoplasm, Inflammatory
- Breast Neoplasms, Inflammatory
- Inflammatory Breast Neoplasm
- Neoplasm, Inflammatory Breast
- Neoplasms, Inflammatory Breast
- Inflammatory Breast Cancer (IBC)
- Inflammatory Breast Carcinoma
- Breast Carcinoma, Inflammatory
- Breast Carcinomas, Inflammatory
- Carcinoma, Inflammatory Breast
- Carcinomas, Inflammatory Breast
- Inflammatory Breast Carcinomas
- Inflammatory Breast Cancer
- Breast Cancer, Inflammatory
- Breast Cancers, Inflammatory
- Cancer, Inflammatory Breast
- Cancers, Inflammatory Breast
- Inflammatory Breast Cancers
|
Below are MeSH descriptors whose meaning is more general than "Inflammatory Breast Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Inflammatory Breast Neoplasms".
This graph shows the total number of publications written about "Inflammatory Breast Neoplasms" by people in this website by year, and whether "Inflammatory Breast Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Inflammatory Breast Neoplasms" by people in Profiles.
-
Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective study. Breast Cancer Res Treat. 2025 Nov; 214(1):69-77.
-
Advances in targets in inflammatory breast cancer. Int Rev Cell Mol Biol. 2024; 384:125-152.
-
Acute and Chronic Effects of Adjuvant Therapy on Inflammatory Markers in Breast Cancer Patients. JNCI Cancer Spectr. 2022 07 01; 6(4).
-
Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer. Ann Surg Oncol. 2021 Dec; 28(13):8610-8621.
-
ASO Visual Abstract: Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer. Ann Surg Oncol. 2021 12; 28(Suppl 3):458-459.
-
Inflammatory breast cancer: early recognition and diagnosis is critical. Am J Obstet Gynecol. 2021 10; 225(4):392-396.
-
Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review. PLoS One. 2021; 16(4):e0250057.
-
The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer. Ann Surg Oncol. 2021 Aug; 28(8):4265-4274.
-
Update on systemic treatment for newly diagnosed inflammatory breast cancer. J Adv Res. 2021 03; 29:1-12.
-
Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery? Ann Surg Oncol. 2020 Nov; 27(12):4603-4612.